Original article
Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study
Factores de riesgo para la progresión de la fibrosis en la esteatohepatitis no alcohólica: análisis de la cohorte europea en el estudio GAIN del mundo real
Anum Shaikha, Gabriel Pedraa, Leonardo Ruiz-Casasa, Bethany Franksa,
, Harpal Dhillona, João Diogo da Rocha Fernandesb, Kamal Kant Manglab, Margarida Augustob, Manuel Romero-Gómezc,d, Jörn M. Schattenberge
Corresponding author
a HCD Economics Ltd., The Innovation Centre, Keckwick Lane, Daresbury, Cheshire WA4 4FS, United Kingdom
b Novo Nordisk A/S, Vandtårnsvej 108, 2860 Søborg, Denmark
c UCM Digestive Diseases and CIBEREHD, 28029 Madrid, Spain
d Virgen del Rocío University Hospital and Institute of Biomedicine of Seville (HUVR/CSIC/US), University of Seville, 41013 Seville, Spain
e Metabolic Liver Research Program, University Medical Center Mainz, Langenbeckstraße 1, 55131 Mainz, Germany
Read
226
Timeswas read the article
63
Total PDF
163
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 27 | 10 | 37 |
| 2024 April | 27 | 13 | 40 |
| 2024 March | 16 | 12 | 28 |
| 2024 February | 15 | 7 | 22 |
| 2024 January | 18 | 1 | 19 |
| 2023 December | 26 | 0 | 26 |
| 2023 November | 34 | 12 | 46 |
| 2023 October | 0 | 8 | 8 |
